Literature DB >> 21392613

Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: a complex relationship.

Sameer Ather1, Wenyaw Chan, Annirudha Chillar, David Aguilar, Allison M Pritchett, Kumudha Ramasubbu, Xander H T Wehrens, Anita Deswal, Biykem Bozkurt.   

Abstract

BACKGROUND: In ambulatory patients with heart failure with reduced ejection fraction (HFrEF), high systolic blood pressure (SBP) is associated with better outcomes. However, it is not known whether there is a ceiling beyond which high SBP has a detrimental effect. Thus, our aim was to assess the linearity of association between SBP and mortality.
METHODS: We used the External Peer Review Program (EPRP) and Digitalis Investigation Group (DIG) trial databases of HFrEF patients. Linearity of association of SBP with mortality was assessed by plotting Martingale residuals against SBP. To assess the patterns of relationship of SBP with mortality, we used restricted cubic spline analysis with Cox proportional hazards model.
RESULTS: In patients with mild-to-moderate left ventricular systolic dysfunction (LVSD) (30% ≤ LVEF < 50%), SBP had a nonlinear association with mortality in both EPRP (n = 3,693) and DIG (n = 3,263) databases. In these patients, SBP had a significant U-shaped association with mortality in EPRP and a trend toward U-shaped relationship in DIG database. In patients with severe LVSD (LVEF <30%), SBP had a linear association with mortality in both EPRP (n = 2,906) and DIG (n = 3,537) databases, with lower SBP being associated with increased mortality.
CONCLUSIONS: Systolic blood pressure has a complex nonlinear association with mortality in patients with heart failure. Whereas it has a U-shaped association in patients with mild-to-moderate LVSD, it has a linear association with mortality in patients with severe LVSD. Recognition of this pattern of association of blood pressure profile may help clinicians in providing better care for their patients and help improve existing prediction models.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21392613      PMCID: PMC3073655          DOI: 10.1016/j.ahj.2010.12.009

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  19 in total

1.  The association between blood pressure and long-term outcomes of patients with ischaemic cardiomyopathy with and without surgical revascularization: an analysis of the STICH trial.

Authors:  Bert Andersson; Lilin She; Ru-San Tan; Panniyammakal Jeemon; Krzysztof Mokrzycki; Matthias Siepe; Alexander Romanov; Liliana E Favaloro; Ljubomir T Djokovic; P Krishnam Raju; Piotr Betlejewski; Normand Racine; Adam Ostrzycki; Weerachai Nawarawong; Siuli Das; Jean L Rouleau; George Sopko; Kerry L Lee; Eric J Velazquez; Julio A Panza
Journal:  Eur Heart J       Date:  2018-10-01       Impact factor: 29.983

2.  Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure.

Authors:  Edoardo Bertero; Roberta Miceli; Alessandra Lorenzoni; Manrico Balbi; Giorgio Ghigliotti; Francesco Chiarella; Claudio Brunelli; Francesca Viazzi; Roberto Pontremoli; Marco Canepa; Pietro Ameri
Journal:  Intern Emerg Med       Date:  2019-03-05       Impact factor: 3.397

Review 3.  Addressing Comorbidities in Heart Failure: Hypertension, Atrial Fibrillation, and Diabetes.

Authors:  Aakash Bavishi; Ravi B Patel
Journal:  Heart Fail Clin       Date:  2020-07-21       Impact factor: 3.179

Review 4.  Autonomic Modulation With Baroreflex Activation Therapy in Heart Failure.

Authors:  Edoardo Gronda; Emilio Vanoli
Journal:  Curr Heart Fail Rep       Date:  2016-12

5.  Use of Heart Failure Medical Therapies Among Patients With Left Ventricular Assist Devices: Insights From INTERMACS.

Authors:  Prateeti Khazanie; Bradley G Hammill; Chetan B Patel; Michael S Kiernan; Lauren B Cooper; Suzanne V Arnold; Timothy J Fendler; John A Spertus; Lesley H Curtis; Adrian F Hernandez
Journal:  J Card Fail       Date:  2016-02-15       Impact factor: 5.712

Review 6.  Effects of renin-angiotensin system blockade on mortality and hospitalization in heart failure with preserved ejection fraction.

Authors:  Vikram Agarwal; Alexandros Briasoulis; Franz H Messerli
Journal:  Heart Fail Rev       Date:  2013-07       Impact factor: 4.214

7.  Comorbid Hypertension Reduces the Risk of Ventricular Arrhythmia in Chronic Heart Failure Patients with Implantable Cardioverter-Defibrillators.

Authors:  Hao Huang; Yu Deng; Sijing Cheng; Nixiao Zhang; Minsi Cai; Hongxia Niu; Xuhua Chen; Min Gu; Xi Liu; Yu Yu; Wei Hua
Journal:  J Clin Med       Date:  2022-05-17       Impact factor: 4.964

8.  Prognostic value of increased carbohydrate antigen in patients with heart failure.

Authors:  Ana B Méndez; Jordi Ordoñez-Llanos; Andreu Ferrero; Mariana Noguero; Teresa Mir; Josefina Mora; Antoni Bayes-Genis; Sònia Mirabet; Juan Cinca; Eulàlia Roig
Journal:  World J Cardiol       Date:  2014-04-26

9.  Patient selection for advanced heart failure therapy referral.

Authors:  Alexander C Fanaroff; Adam D DeVore; Robert J Mentz; Mani A Daneshmand; Chetan B Patel
Journal:  Crit Pathw Cardiol       Date:  2014-03

10.  Systolic Blood Pressure and Outcomes in Older Patients with HFpEF and Hypertension.

Authors:  Charles Faselis; Phillip H Lam; Michael R Zile; Poonam Bhyan; Apostolos Tsimploulis; Cherinne Arundel; Samir Patel; Peter Kokkinos; Prakash Deedwania; Deepak L Bhatt; Qing Zeng-Trietler; Charity J Morgan; Wilbert S Aronow; Richard M Allman; Gregg C Fonarow; Ali Ahmed
Journal:  Am J Med       Date:  2020-09-30       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.